Schedule 13D ownership disclosure

Elicio Therapeutics, Inc.

Common Stock, par value $0.01 per share · CUSIP: 28657F103

Event date: 2025-06-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • GKCC, LLCReported CIK 0001977769

    Shares: 9,752,139 · Class: 48%

  • Yekaterina ChudnovskyReported CIK 0001979324

    Shares: 9,764,864 · Class: 48%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-081739
Form type
SCHEDULE 13D/A
Filer
Elicio Therapeutics, Inc.
CIK
CIK 1601485
Filed
Jun 04, 2025
Reporting period
Jun 03, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub